126 related articles for article (PubMed ID: 38647571)
1. Promising anticancer activity of cromolyn in colon cancer: in vitro and in vivo analysis.
Aliabadi A; Haghshenas MR; Kiani R; Panjehshahin MR; Erfani N
J Cancer Res Clin Oncol; 2024 Apr; 150(4):207. PubMed ID: 38647571
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning.
Aliabadi A; Haghshenas MR; Kiani R; Koohi-Hosseinabadi O; Purkhosrow A; Pirsalami F; Panjehshahin MR; Erfani N
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2379-2388. PubMed ID: 37837472
[TBL] [Abstract][Full Text] [Related]
3. Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor.
Shi J; Li J; Li J; Li R; Wu X; Gao F; Zou L; Mak WWS; Fu C; Zhang J; Leung GP
Phytomedicine; 2021 Jan; 81():153408. PubMed ID: 33234363
[TBL] [Abstract][Full Text] [Related]
4. Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors.
Oh Y; Swierczewska M; Kim TH; Lim SM; Eom HN; Park JH; Na DH; Kim K; Lee KC; Pomper MG; Lee S
J Control Release; 2015 Dec; 220(Pt B):671-81. PubMed ID: 26381901
[TBL] [Abstract][Full Text] [Related]
5. A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer.
Yalikong A; Li XQ; Zhou PH; Qi ZP; Li B; Cai SL; Zhong YS
Int J Nanomedicine; 2021; 16():2323-2335. PubMed ID: 33776436
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of histone deacetylases by trans-cinnamic acid and its antitumor effect against colon cancer xenografts in athymic mice.
Zhu B; Shang B; Li Y; Zhen Y
Mol Med Rep; 2016 May; 13(5):4159-66. PubMed ID: 27035417
[TBL] [Abstract][Full Text] [Related]
7. The Blepharis persica seed hydroalcoholic extract synergistically enhances the apoptotic effect of doxorubicin in human colon cancer and gastric cancer cells.
Aghaabbasi K; Askari N; Hassani Kumleh H; Torkzadeh-Mahani M; Ramzani-Ghara A
Mol Biol Rep; 2020 Feb; 47(2):843-853. PubMed ID: 31848915
[TBL] [Abstract][Full Text] [Related]
8. Induction of HT-29 Colon Cancer Cells Apoptosis by Pyrogallol with Growth Inhibiting Efficacy Against Drug-Resistant
Revathi S; Hakkim FL; Kumar NR; Bakshi HA; Rashan L; Al-Buloshi M; Hasson SSAA; Krishnan M; Javid F; Nagarajan K
Anticancer Agents Med Chem; 2018; 18(13):1875-1884. PubMed ID: 30081791
[TBL] [Abstract][Full Text] [Related]
9. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
Cai D; Qiu Z; Yao W; Liu Y; Huang H; Liao S; Luo Q; Xie L; Lin Z
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1217-29. PubMed ID: 27107592
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis.
Hu Y; Zhang K; Zhu X; Zheng X; Wang C; Niu X; Jiang T; Ji X; Zhao W; Pang L; Qi Y; Li F; Li L; Xu Z; Gu W; Zou H
Int J Nanomedicine; 2021; 16():2173-2186. PubMed ID: 33758505
[TBL] [Abstract][Full Text] [Related]
11. In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer.
Kim CE; Lim SK; Kim JS
J Control Release; 2012 Jan; 157(2):190-5. PubMed ID: 21963773
[TBL] [Abstract][Full Text] [Related]
12. [Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
Shang BY; Shang Y; Zhen YS; Chen SZ
Yao Xue Xue Bao; 2011 Nov; 46(11):1321-5. PubMed ID: 22260022
[TBL] [Abstract][Full Text] [Related]
13. Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer
Wang W; Li Y; Chen Y; Chen H; Zhu P; Xu M; Wang H; Wu M; Yang Z; Hoffman RM; Gu Y
Anticancer Res; 2018 Apr; 38(4):1917-1925. PubMed ID: 29599307
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and Apoptosis Effects of Curcumin Analogue (2E,6E)-2,6-Bis(2,3-Dimethoxybenzylidine) Cyclohexanone (DMCH) on Human Colon Cancer Cells HT29 and SW620 In Vitro.
Rahim NFC; Hussin Y; Aziz MNM; Mohamad NE; Yeap SK; Masarudin MJ; Abdullah R; Akhtar MN; Alitheen NB
Molecules; 2021 Feb; 26(5):. PubMed ID: 33652694
[TBL] [Abstract][Full Text] [Related]
15. Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin.
Ravizza R; Gariboldi MB; Passarelli L; Monti E
BMC Cancer; 2004 Dec; 4():92. PubMed ID: 15601469
[TBL] [Abstract][Full Text] [Related]
16. Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer.
Tu S; Wai-Yin Sun R; Lin MC; Tao Cui J; Zou B; Gu Q; Kung HF; Che CM; Wong BC
Cancer; 2009 Oct; 115(19):4459-69. PubMed ID: 19572413
[TBL] [Abstract][Full Text] [Related]
17. siRNA targeting Livin decreases tumor in a xenograft model for colon cancer.
Oh BY; Lee RA; Kim KH
World J Gastroenterol; 2011 May; 17(20):2563-71. PubMed ID: 21633662
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight.
Rai G; Mishra S; Suman S; Shukla Y
Phytomedicine; 2016 Mar; 23(3):233-42. PubMed ID: 26969377
[TBL] [Abstract][Full Text] [Related]
19. Ophiopogonin B induces the autophagy and apoptosis of colon cancer cells by activating JNK/c-Jun signaling pathway.
Gao GY; Ma J; Lu P; Jiang X; Chang C
Biomed Pharmacother; 2018 Dec; 108():1208-1215. PubMed ID: 30372822
[TBL] [Abstract][Full Text] [Related]
20. Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy.
Kang XJ; Wang HY; Peng HG; Chen BF; Zhang WY; Wu AH; Xu Q; Huang YZ
Acta Pharmacol Sin; 2017 Jun; 38(6):885-896. PubMed ID: 28479604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]